S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
AGEN · Agenus Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$6.40
-0.02
(-0.39%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$6.40
$6.36
$6.53
52-WEEK RANGE
$6.40
$2.71
$10.31
What's happening
- AGEN is down 0.39% today, trading at $6.40. — Live quote
- Volume today (75,955) is well below its 3-month average of 3,294,770. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.01 actual vs. $0.05 estimated (-119.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 6
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (9 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
AGEN
+103.82%
vs S&P 500
+90.45%
1-YEAR RETURN
AGEN
+49.18%
vs S&P 500
+34.02%
6-MONTH RETURN
AGEN
+33.61%
3-MONTH RETURN
AGEN
+15.73%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.01
Est. $0.05
MISS -119.6%
2026-04-26 (Q1 2026)
$0.00
Est. $2.14
MISS -100.0%
2026-01-26 (Q4 2025)
$-0.31
Est. $-1.07
BEAT +71.1%
2025-10-26 (Q3 2025)
$1.94
Est. $2.02
MISS -3.9%
Valuation Measures & Ratios
Enterprise Value4$553.9M
Forward P/E5149.10
PEG Ratio6—
Price / Sales (TTM1)2.21
Price / Book7153.49
EV4 / Revenue4.17
EV4 / EBITDA3.91
Profit Margin69.34%
Operating Margin103.19%
Return on Equity (ROE8)76.63%
Return on Assets (ROA9)44.89%
Avg Volume (3M)3,294,770
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short6,818,562
Change from Prior Settlement+0.22%
% of Float—
Days to Cover (Short Ratio)5.66
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 34.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 69.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is +49.2%. Finnhub market metrics ↗
Potential concerns
- Latest SEC filing is Form 4, filed 2026-10-02; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on AGEN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.5M | $33.7M | $30.2M | $25.7M | $24.1M | $25.1M | $23.5M | $28.0M |
| Operating income | $11.3M | $15.1M | -$4.5M | -$16.7M | -$13.3M | -$31.5M | -$30.2M | -$32.9M |
| Net income | — | — | — | — | — | — | — | — |
| EPS (diluted) | $-0.01 | $1.02 | $1.94 | $-1.00 | $-1.03 | $-3.08 | $-2.52 | $-3.04 |
| EPS (basic) | $-0.01 | $1.03 | $2.00 | $-1.00 | $-1.03 | $-3.08 | $-2.52 | $-3.04 |
| Operating margin | $33 | $45 | -$15 | -$65 | -$55 | -$125 | -$128 | -$117 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $172.7M | $186.5M | $226.8M | $233.9M | $185.2M | $200.2M | $226.3M | $238.5M |
| Stockholders' equity | -$199.1M | -$221.2M | -$271.1M | -$274.1M | -$354.6M | -$341.8M | -$326.4M | -$292.3M |
| Total current assets | $78.8M | $95.3M | $133.4M | $133.9M | $13.3M | $23.1M | $45.6M | $50.2M |
| Total current liabilities | $231.8M | $249.2M | $323.5M | $287.1M | $234.6M | $208.3M | $221.4M | $270.6M |
| Cash & equivalents | $18.7M | $35.0M | $3.0M | $3.5M | $9.5M | $18.5M | $40.4M | $44.8M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $14.7M | $6.6M | $1.8M | $538.0K | $709.0K | $354.0K | $407.0K | $207.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Other current assets | $2.0M | $2.0M | $1.1M | $1.2M | $1.8M | $2.4M | $2.4M | $2.8M |
| Property, plant & equipment | $14.3M | $14.9M | $15.5M | $16.0M | $112.7M | $117.0M | $120.1M | $124.5M |
| Goodwill | $24.1M | $24.1M | $24.1M | $24.1M | $24.1M | $24.1M | $24.1M | $24.7M |
| Intangible assets | $2.9M | $3.0M | $3.0M | $3.1M | $3.2M | $3.3M | $3.4M | $4.0M |
| Other non-current assets | $3.9M | $3.0M | $3.3M | $3.2M | $5.4M | $5.6M | $5.8M | $6.6M |
| Accounts payable | $59.0M | $71.1M | $83.0M | $85.3M | $74.4M | $64.2M | $61.5M | $45.9M |
| Accrued liabilities | $27.5M | $37.0M | $34.2M | $31.8M | $39.3M | $36.4M | $35.0M | $36.7M |
| Deferred revenue (current) | — | — | $0 | $45.0K | $45.0K | $14.0K | $31.0K | $10.0K |
| Short-term debt | $30.1M | $30.2M | $44.7M | $10.6M | $10.7M | $731.0K | $2.7M | $13.4M |
| Other current liabilities | $480.0K | $514.0K | $529.0K | $710.0K | $3.9M | $5.0M | $7.8M | $12.6M |
| Long-term debt | $30.1M | $30.2M | $44.7M | $34.2M | $33.9M | $33.6M | $33.2M | — |
| Other non-current liabilities | $247.0K | $247.0K | $259.0K | $376.0K | $752.0K | $761.0K | $738.0K | $777.0K |
| Common stock & paid-in capital | $427.0K | $385.0K | $353.0K | $329.0K | $300.0K | $266.0K | $236.0K | $217.0K |
| Retained earnings | -$2.14B | -$2.14B | -$2.18B | -$2.17B | -$2.24B | -$2.21B | -$2.18B | -$2.14B |
| Accumulated other comprehensive income (loss) | -$450.0K | -$437.0K | -$439.0K | -$1.6M | -$1.5M | -$1.5M | -$1.4M | -$1.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$31.2M | -$36.0M | -$16.6M | -$14.7M | -$20.2M | -$25.6M | -$28.7M | -$53.3M |
| Investing cash flow | $267.0K | $69.0M | $780.0K | $76.0K | $281.0K | $57.0K | -$21.0K | $56.0K |
| Financing cash flow | $14.7M | -$993.0K | $15.4M | $6.7M | $10.9M | $3.6M | $24.4M | $4.6M |
| Free cash flow | -$31.2M | -$36.0M | -$16.6M | -$14.7M | -$20.2M | -$25.6M | -$28.7M | -$53.3M |
| Capital expenditures | $0 | $0 | $0 | $0 | $1.0K | $5.0K | $73.0K | $7.0K |
| Share-based compensation | $3.6M | $1.1M | $3.5M | $3.2M | $3.6M | $3.5M | $4.7M | $4.5M |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | $8.2M | $4.7M | $1.7M | -$183.0K | $340.0K | -$108.0K | $269.0K | -$492.0K |
| Change in inventory | — | — | — | — | — | — | — | — |
| Change in accounts payable | -$12.1M | -$11.9M | -$3.3M | $14.1M | $10.1M | $2.6M | $15.7M | -$5.0M |
| Purchases of investments | — | — | $0 | — | — | — | — | — |
| Sales/maturities of investments | — | — | $0 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | $0 | $8.4M | $0 | $0 | $0 | $2.5M | — | $0 |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $114.2M | $103.5M | $156.3M | $98.0M | $295.7M |
| Operating income | -$20.2M | -$120.5M | -$159.5M | -$179.4M | $25.7M |
| Net income | — | — | — | — | — |
| EPS (diluted) | $0.00 | $-10.59 | $-13.75 | $-15.64 | $-0.11 |
| EPS (basic) | $0.00 | $-10.59 | $-13.75 | $-15.64 | $-0.11 |
| Operating margin | -$18 | -$116 | -$102 | -$183 | $9 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $226.8M | $226.3M | $313.9M | $413.6M | $466.0M |
| Stockholders' equity | -$271.1M | -$326.4M | -$160.3M | -$61.3M | $34.4M |
| Total current assets | $133.4M | $45.6M | $112.4M | $213.1M | $332.0M |
| Total current liabilities | $323.5M | $221.4M | $255.9M | $189.0M | $156.9M |
| Cash & equivalents | $3.0M | $40.4M | $76.1M | $178.7M | $291.9M |
| Marketable securities (current) | — | — | — | $14.7M | $15.0M |
| Accounts receivable | $1.8M | $407.0K | $25.8M | $2.7M | $1.5M |
| Inventory | — | — | — | — | — |
| Other current assets | $1.1M | $2.4M | $2.4M | $3.2M | $3.2M |
| Property, plant & equipment | $15.5M | $120.1M | $133.4M | $133.0M | $60.0M |
| Goodwill | $24.1M | $24.1M | $24.7M | $25.5M | $24.9M |
| Intangible assets | $3.0M | $3.4M | $4.4M | $6.2M | $8.5M |
| Other non-current assets | $3.3M | $5.8M | $9.3M | $4.5M | $9.5M |
| Accounts payable | $83.0M | $61.5M | $61.4M | $40.9M | $30.5M |
| Accrued liabilities | $34.2M | $35.0M | $45.3M | $38.3M | $42.1M |
| Deferred revenue (current) | $0 | $31.0K | $18.0K | $12.3M | $12.4M |
| Short-term debt | $44.7M | $2.7M | $146.0K | $575.0K | $728.0K |
| Other current liabilities | $529.0K | $7.8M | $13.9M | $11.5M | $6.5M |
| Long-term debt | $44.7M | $33.2M | — | — | — |
| Other non-current liabilities | $259.0K | $738.0K | $5.4M | $14.7M | $1.6M |
| Common stock & paid-in capital | $353.0K | $236.0K | $197.0K | $3.1M | $2.6M |
| Retained earnings | -$2.18B | -$2.18B | -$1.96B | -$1.71B | -$1.49B |
| Accumulated other comprehensive income (loss) | -$439.0K | -$1.4M | -$955.0K | $915.0K | $1.5M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$77.2M | -$158.3M | -$224.2M | -$175.4M | $10.1M |
| Investing cash flow | $1.2M | $27.0K | $3.4M | -$33.6M | -$43.1M |
| Financing cash flow | $36.6M | $122.8M | $119.9M | $95.8M | $225.3M |
| Free cash flow | -$77.2M | -$158.9M | -$234.2M | -$228.4M | -$23.7M |
| Capital expenditures | $6.0K | $576.0K | $10.0M | $53.1M | $33.8M |
| Share-based compensation | $13.8M | $17.4M | $22.9M | $18.3M | $19.6M |
| Deferred income taxes | $0 | $0 | $0 | — | — |
| Change in accounts receivable | $1.7M | -$25.3M | $23.5M | -$122.0K | $394.0K |
| Change in inventory | — | — | — | — | — |
| Change in accounts payable | $23.5M | $2.0M | $21.4M | $6.5M | $10.8M |
| Purchases of investments | $0 | — | $14.6M | $24.6M | $15.0M |
| Sales/maturities of investments | $0 | — | $30.0M | $25.0M | — |
| Share repurchases | — | — | — | — | — |
| Debt issued | — | — | — | — | — |
| Debt repaid | $2.5M | — | — | — | — |
| Tax withholding on stock comp | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding AGEN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 31 filers
Held by These Filers32.9%
Shares Outstanding41,338,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,564,884 | $7.8M | 6.20% | +370.0% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,676,096 | $5.1M | 4.05% | +16.4% | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,427,587 | $4.4M | 3.45% | +19.5% | 2026-06-30 |
| Siren, L.L.C. | 1,064,250 | $3.3M | 2.57% | +0.0% | 2026-08-13 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,035,040 | $3.2M | 2.50% | +197.1% | 2026-08-12 |
| MACKENZIE FINANCIAL CORP | 714,175 | $2.2M | 1.73% | +0.0% | 2026-08-13 |
| Goldman Sachs Group Inc | 448,383 | $1.4M | 1.08% | +1325.5% | 2026-08-14 |
| MARSHALL WACE, LLP | 439,621 | $1.3M | 1.06% | -36.1% | 2026-08-13 |
| Raymond James Financial Inc | 430,078 | $1.3M | 1.04% | +79.5% | 2026-08-14 |
| GLOBEFLEX CAPITAL L P | 418,581 | $1.3M | 1.01% | +0.0% | 2026-08-12 |
| State Street Corp | 412,383 | $1.3M | 1.00% | +164.0% | 2026-08-07 |
| Man Group plc | 340,425 | $1.0M | 0.82% | +22.0% | 2026-08-14 |
| Northern Trust Corp | 314,052 | $961.0K | 0.76% | +250.0% | 2026-08-12 |
| Connor, Clark & Lunn Investment Management Ltd. | 310,035 | $948.7K | 0.75% | +56.2% | 2026-08-12 |
| VANGUARD FIDUCIARY TRUST CO | 271,614 | $831.1K | 0.66% | +35.5% | 2026-06-30 |
| Morgan Stanley | 262,068 | $801.9K | 0.63% | -11.4% | 2026-08-11 |
| RENAISSANCE TECHNOLOGIES LLC | 228,346 | $698.7K | 0.55% | -20.1% | 2026-08-13 |
| PANAGORA ASSET MANAGEMENT INC | 179,589 | $549.5K | 0.43% | +10.1% | 2026-08-06 |
| Susquehanna Portfolio Strategies, LLC | 158,737 | $485.7K | 0.38% | +0.0% | 2026-08-14 |
| Jump Financial, LLC | 103,981 | $318.2K | 0.25% | -33.9% | 2026-08-13 |
| Bank of New York Mellon Corp | 101,773 | $311.4K | 0.25% | +0.0% | 2026-08-06 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 99,392 | $304.1K | 0.24% | +562.6% | 2026-08-14 |
| Sixth Street Partners Management Company, L.P. | 99,392 | $304.1K | 0.24% | +0.0% | 2026-08-13 |
| TWO SIGMA INVESTMENTS, LP | 98,685 | $302.0K | 0.24% | -42.3% | 2026-08-07 |
| STRS OHIO | 76,900 | $235.3K | 0.19% | +0.0% | 2026-07-30 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-01 to 2026-10-01
Recent transactions
- Most recent: HARRISON THOMAS L (Reporting person) — Grant / award of 4,443 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| HARRISON THOMAS L | Reporting person | Grant / award | 2026-10-01 | 4,443 |
| ARMEN GARO H | See Remarks | Grant / award | 2026-07-10 | 4,852 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | HARRISON THOMAS L | Reporting person | Grant / award | 4,443 | $6.89 |
| 2026-07-10 | ARMEN GARO H | See Remarks | Grant / award | 4,852 | $3.35 |
| 2026-07-01 | HARRISON THOMAS L | Reporting person | Grant / award | 8,547 | $3.58 |
| 2026-06-26 | ARMEN GARO H | See Remarks | Grant / award | 5,364 | $3.03 |
| 2026-06-12 | ARMEN GARO H | See Remarks | Grant / award | 4,925 | $3.30 |
| 2026-05-29 | ARMEN GARO H | See Remarks | Grant / award | 4,644 | $3.50 |
| 2026-05-15 | ARMEN GARO H | See Remarks | Grant / award | 4,540 | $3.58 |
| 2026-05-01 | ARMEN GARO H | See Remarks | Grant / award | 4,233 | $3.84 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:34 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-08-05 | View on SEC.gov → |
| 2026-08-18 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-11 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-05 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-05 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-05 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-05 | View on SEC.gov → |
Recent news
Headlines about AGEN (Agenus Inc.). Links open the publisher — we don’t host full articles.
-
Agenus Pivots BOT/BAL Strategy to Phase III Colon Cancer Trial
Yahoo · 2026-10-20 -
AGEN270115C00013000 Interactive Stock Chart | AGEN Jan 2027 13.000 call Stock
Yahoo! Finance Canada · 2026-10-20 -
AGEN Jan 2027 13.000 call (AGEN270115C00013000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-20 -
Agenus at Chardan’s 10th annual healthcare conference: pivot to ROBIN
Investing.com · 2026-10-20 -
Form 4 Agenus Inc: Thomas L. Harrison (Director) For: 1 October
Investing.com Canada · 2026-10-18 -
Form 4 Agenus Inc: Timothy Wright (Director) For: 1 October By Investing.com
Investing.com Nigeria · 2026-10-18 -
(AGEN) Price Dynamics and Execution-Aware Positioning
Stock Traders Daily · 2026-10-18 -
AGEN Jan 2028 10.000 put (AGEN280121P00010000) interactive stock chart
Yahoo Finance UK · 2026-10-17
No headlines in this category right now — try “All”.